Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its participation in the forthcoming Annual JP Morgan Healthcare Conference in San Francisco, on January 13 to 16, 2014.
Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference
Monday, December 30, 2013
Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment